Mazzei T, Tonelli F, Mini E, Mazzoni P, Pesciullesi A, Valanzano R, Ficari F, Biondi C, Periti P
Dipartimento di Farmacologia, Università degli Studi, Firenze, Italy.
Anticancer Res. 1995 Sep-Oct;15(5B):2247-53.
The aim of this study was to evaluate the relationship between DNA ploidy, proliferative activity and other prognostic factors and the survival of patients with colorectal cancer. 45 patients were prospectively investigated for 6 years. Fresh multiple samples for flow cytometric analysis of DNA content were collected during surgical resection of primary tumor. A 42% frequency of aneuploidy was observed with a median DNA index value of 1.54. The proliferative activity (%S+G2M cells) was higher in the aneuploid cell sub-population (28.6%) compared to the diploid counterpart (22.7%)(p = 0.05). No significant relationship between DNA ploidy and tumor site, Dukes' stage, histological type, grading age or sex was observed. No correlation between DNA ploidy and survival was demonstrated, including in the analysis of patient subsets according to stage. No additive prognostic information was obtained from a breakdown analysis as a function of DI values, percentages of aneuploid cells and proliferative activity. This study suggests that flow cytometric content analysis lacks prognostic value in colorectal carcinoma.
本研究的目的是评估DNA倍体、增殖活性及其他预后因素与结直肠癌患者生存率之间的关系。对45例患者进行了为期6年的前瞻性研究。在原发性肿瘤手术切除期间收集新鲜多样的样本,用于DNA含量的流式细胞术分析。观察到非整倍体频率为42%,DNA指数中位数为1.54。与二倍体细胞亚群(22.7%)相比,非整倍体细胞亚群(28.6%)的增殖活性(%S+G2M细胞)更高(p = 0.05)。未观察到DNA倍体与肿瘤部位、Dukes分期、组织学类型、分级、年龄或性别之间存在显著关系。未证明DNA倍体与生存率之间存在相关性,包括在根据分期对患者亚组进行的分析中。根据DI值、非整倍体细胞百分比和增殖活性进行的细分分析未获得额外的预后信息。本研究表明,流式细胞术含量分析在结直肠癌中缺乏预后价值。